Gifu, Japan

Takeshi Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Watanabe. Retrieved from https://idiyas.com/inventor/takeshi-watanabe-cc1xvp6c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takeshi Watanabe

Introduction

Takeshi Watanabe is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of coronary function improvement. His innovative work has led to the development of a unique composition that enhances the absorption of ubidecarenone.

Latest Patents

Watanabe holds a patent for a composition containing ubidecarenone, a glycerol mono-fatty acid ester, and/or a propylene glycol mono-fatty acid ester, along with a liquid oil. This composition is designed for oral administration, which promotes the absorption of ubidecarenone, a compound known for its potential benefits in improving coronary function.

Career Highlights

Takeshi Watanabe is currently employed at Eisai Company, Limited, a leading global pharmaceutical company. His work at Eisai has allowed him to focus on innovative solutions that address critical health issues. With one patent to his name, Watanabe has established himself as a valuable contributor to the field of medical research.

Collaborations

Watanabe has collaborated with esteemed colleagues such as Yasuharu Saeki and Takayuki Ohwaki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Takeshi Watanabe's contributions to the pharmaceutical industry exemplify the impact of innovation on health and wellness. His patented composition for enhancing ubidecarenone absorption showcases his commitment to improving coronary function. Watanabe's work continues to inspire advancements in medical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…